nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2B6—Cholecalciferol—psoriasis	0.0734	0.112	CbGbCtD
Clobazam—CYP2C19—Cholecalciferol—psoriasis	0.0466	0.0709	CbGbCtD
Clobazam—CYP3A4—Calcitriol—psoriasis	0.0438	0.0665	CbGbCtD
Clobazam—CYP3A4—Methoxsalen—psoriasis	0.034	0.0517	CbGbCtD
Clobazam—ABCB1—Mycophenolate mofetil—psoriasis	0.0326	0.0496	CbGbCtD
Clobazam—CYP2C19—Prednisone—psoriasis	0.0323	0.0491	CbGbCtD
Clobazam—CYP2B6—Dexamethasone—psoriasis	0.0318	0.0483	CbGbCtD
Clobazam—CYP2C19—Cyclosporine—psoriasis	0.0307	0.0466	CbGbCtD
Clobazam—ABCB1—Betamethasone—psoriasis	0.028	0.0425	CbGbCtD
Clobazam—ABCB1—Prednisolone—psoriasis	0.0276	0.042	CbGbCtD
Clobazam—ABCB1—Hydrocortisone—psoriasis	0.0262	0.0398	CbGbCtD
Clobazam—ABCB1—Prednisone—psoriasis	0.0261	0.0396	CbGbCtD
Clobazam—ABCB1—Cyclosporine—psoriasis	0.0247	0.0376	CbGbCtD
Clobazam—CYP3A4—Cholecalciferol—psoriasis	0.0226	0.0343	CbGbCtD
Clobazam—CYP2C19—Dexamethasone—psoriasis	0.0202	0.0307	CbGbCtD
Clobazam—CYP3A4—Triamcinolone—psoriasis	0.0196	0.0297	CbGbCtD
Clobazam—CYP3A4—Mycophenolate mofetil—psoriasis	0.0196	0.0297	CbGbCtD
Clobazam—CYP3A4—Betamethasone—psoriasis	0.0168	0.0255	CbGbCtD
Clobazam—CYP3A4—Prednisolone—psoriasis	0.0166	0.0251	CbGbCtD
Clobazam—ABCB1—Dexamethasone—psoriasis	0.0163	0.0247	CbGbCtD
Clobazam—CYP3A4—Hydrocortisone—psoriasis	0.0157	0.0238	CbGbCtD
Clobazam—CYP3A4—Prednisone—psoriasis	0.0156	0.0237	CbGbCtD
Clobazam—CYP3A4—Cyclosporine—psoriasis	0.0148	0.0225	CbGbCtD
Clobazam—ABCB1—Methotrexate—psoriasis	0.0131	0.0199	CbGbCtD
Clobazam—CYP3A4—Dexamethasone—psoriasis	0.00976	0.0148	CbGbCtD
Clobazam—CYP2C18—Xenobiotics—CYP2S1—psoriasis	0.00305	0.0802	CbGpPWpGaD
Clobazam—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00242	0.0637	CbGpPWpGaD
Clobazam—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00183	0.0481	CbGpPWpGaD
Clobazam—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.0015	0.0395	CbGpPWpGaD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00147	0.0385	CbGpPWpGaD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00127	0.0333	CbGpPWpGaD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00125	0.0329	CbGpPWpGaD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00118	0.031	CbGpPWpGaD
Clobazam—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00113	0.0298	CbGpPWpGaD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00103	0.027	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—TGFA—psoriasis	0.00101	0.0265	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL22—psoriasis	0.000889	0.0234	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—TGFA—psoriasis	0.000812	0.0213	CbGpPWpGaD
Clobazam—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000682	0.0179	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—CP—psoriasis	0.000666	0.0175	CbGpPWpGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000623	0.0164	CbGpPWpGaD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000615	0.0162	CbGpPWpGaD
Clobazam—SLC6A1—Monoamine Transport—TNF—psoriasis	0.000605	0.0159	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—CYP2S1—psoriasis	0.000546	0.0143	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP2S1—psoriasis	0.000539	0.0142	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000537	0.0141	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000505	0.0133	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000471	0.0124	CbGpPWpGaD
Clobazam—CYP2C18—Tryptophan metabolism—CAT—psoriasis	0.000471	0.0124	CbGpPWpGaD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000465	0.0122	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000382	0.01	CbGpPWpGaD
Clobazam—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000368	0.00966	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—NDUFA5—psoriasis	0.000364	0.00957	CbGpPWpGaD
Clobazam—GABRB2—Orphan transporters—CARM1—psoriasis	0.000361	0.00948	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—CP—psoriasis	0.000338	0.00889	CbGpPWpGaD
Clobazam—GABRG2—Orphan transporters—CARM1—psoriasis	0.00033	0.00867	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—CARM1—psoriasis	0.000323	0.00848	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYP2S1—psoriasis	0.00031	0.00813	CbGpPWpGaD
Clobazam—Infection—Cyclosporine—psoriasis	0.000289	0.000952	CcSEcCtD
Clobazam—GABRA1—Orphan transporters—CARM1—psoriasis	0.000288	0.00758	CbGpPWpGaD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000286	0.00753	CbGpPWpGaD
Clobazam—Confusional state—Mycophenolate mofetil—psoriasis	0.000286	0.000942	CcSEcCtD
Clobazam—Nervous system disorder—Cyclosporine—psoriasis	0.000285	0.000939	CcSEcCtD
Clobazam—Thrombocytopenia—Cyclosporine—psoriasis	0.000285	0.000938	CcSEcCtD
Clobazam—Body temperature increased—Mycophenolic acid—psoriasis	0.000284	0.000936	CcSEcCtD
Clobazam—Dizziness—Hydroxyurea—psoriasis	0.000284	0.000935	CcSEcCtD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000283	0.00744	CbGpPWpGaD
Clobazam—Asthma—Methotrexate—psoriasis	0.000283	0.000931	CcSEcCtD
Clobazam—Skin disorder—Cyclosporine—psoriasis	0.000282	0.00093	CcSEcCtD
Clobazam—Infection—Mycophenolate mofetil—psoriasis	0.000282	0.000928	CcSEcCtD
Clobazam—Hyperhidrosis—Cyclosporine—psoriasis	0.000281	0.000926	CcSEcCtD
Clobazam—Eosinophilia—Methotrexate—psoriasis	0.00028	0.000922	CcSEcCtD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00028	0.00735	CbGpPWpGaD
Clobazam—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000278	0.000916	CcSEcCtD
Clobazam—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000278	0.000915	CcSEcCtD
Clobazam—Anorexia—Cyclosporine—psoriasis	0.000277	0.000913	CcSEcCtD
Clobazam—Skin disorder—Mycophenolate mofetil—psoriasis	0.000276	0.000908	CcSEcCtD
Clobazam—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000274	0.000903	CcSEcCtD
Clobazam—Vomiting—Hydroxyurea—psoriasis	0.000273	0.000899	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—CP—psoriasis	0.000273	0.00717	CbGpPWpGaD
Clobazam—Rash—Hydroxyurea—psoriasis	0.000271	0.000891	CcSEcCtD
Clobazam—Anorexia—Mycophenolate mofetil—psoriasis	0.00027	0.000891	CcSEcCtD
Clobazam—Dermatitis—Hydroxyurea—psoriasis	0.00027	0.00089	CcSEcCtD
Clobazam—Myalgia—Hydrocortisone—psoriasis	0.00027	0.000888	CcSEcCtD
Clobazam—Hallucination—Prednisone—psoriasis	0.000269	0.000887	CcSEcCtD
Clobazam—Headache—Hydroxyurea—psoriasis	0.000269	0.000886	CcSEcCtD
Clobazam—Anxiety—Hydrocortisone—psoriasis	0.000269	0.000885	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000268	0.00705	CbGpPWpGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000268	0.000882	CcSEcCtD
Clobazam—Hypotension—Mycophenolate mofetil—psoriasis	0.000265	0.000873	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000265	0.000873	CcSEcCtD
Clobazam—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000265	0.00696	CbGpPWpGaD
Clobazam—Insomnia—Cyclosporine—psoriasis	0.000263	0.000866	CcSEcCtD
Clobazam—Upper respiratory tract infection—Methotrexate—psoriasis	0.000263	0.000865	CcSEcCtD
Clobazam—Cough—Triamcinolone—psoriasis	0.00026	0.000857	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.00026	0.00684	CbGpPWpGaD
Clobazam—Somnolence—Cyclosporine—psoriasis	0.000259	0.000852	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000258	0.000851	CcSEcCtD
Clobazam—Asthenia—Mycophenolic acid—psoriasis	0.000258	0.000849	CcSEcCtD
Clobazam—Infection—Hydrocortisone—psoriasis	0.000257	0.000846	CcSEcCtD
Clobazam—Insomnia—Mycophenolate mofetil—psoriasis	0.000257	0.000845	CcSEcCtD
Clobazam—Hyperhidrosis—Prednisolone—psoriasis	0.000256	0.000843	CcSEcCtD
Clobazam—Nausea—Hydroxyurea—psoriasis	0.000255	0.00084	CcSEcCtD
Clobazam—Pruritus—Mycophenolic acid—psoriasis	0.000254	0.000838	CcSEcCtD
Clobazam—Myalgia—Triamcinolone—psoriasis	0.000254	0.000836	CcSEcCtD
Clobazam—Nervous system disorder—Hydrocortisone—psoriasis	0.000253	0.000835	CcSEcCtD
Clobazam—Pneumonia—Methotrexate—psoriasis	0.000253	0.000835	CcSEcCtD
Clobazam—Eye disorder—Prednisone—psoriasis	0.000253	0.000833	CcSEcCtD
Clobazam—Decreased appetite—Cyclosporine—psoriasis	0.000253	0.000833	CcSEcCtD
Clobazam—Somnolence—Mycophenolate mofetil—psoriasis	0.000252	0.000831	CcSEcCtD
Clobazam—Infestation NOS—Methotrexate—psoriasis	0.000252	0.00083	CcSEcCtD
Clobazam—Infestation—Methotrexate—psoriasis	0.000252	0.00083	CcSEcCtD
Clobazam—Drowsiness—Methotrexate—psoriasis	0.000252	0.00083	CcSEcCtD
Clobazam—Depression—Methotrexate—psoriasis	0.000251	0.000828	CcSEcCtD
Clobazam—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000251	0.000827	CcSEcCtD
Clobazam—Skin disorder—Hydrocortisone—psoriasis	0.000251	0.000827	CcSEcCtD
Clobazam—Fatigue—Cyclosporine—psoriasis	0.000251	0.000826	CcSEcCtD
Clobazam—Hyperhidrosis—Hydrocortisone—psoriasis	0.00025	0.000823	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00025	0.000823	CcSEcCtD
Clobazam—Constipation—Cyclosporine—psoriasis	0.000249	0.000819	CcSEcCtD
Clobazam—Dry mouth—Triamcinolone—psoriasis	0.000248	0.000818	CcSEcCtD
Clobazam—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000247	0.000812	CcSEcCtD
Clobazam—Anorexia—Hydrocortisone—psoriasis	0.000246	0.000811	CcSEcCtD
Clobazam—Diarrhoea—Mycophenolic acid—psoriasis	0.000246	0.00081	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000245	0.00644	CbGpPWpGaD
Clobazam—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000245	0.000807	CcSEcCtD
Clobazam—Constipation—Mycophenolate mofetil—psoriasis	0.000243	0.000799	CcSEcCtD
Clobazam—Infection—Triamcinolone—psoriasis	0.000242	0.000796	CcSEcCtD
Clobazam—Sweating—Methotrexate—psoriasis	0.000242	0.000796	CcSEcCtD
Clobazam—Hypotension—Hydrocortisone—psoriasis	0.000241	0.000795	CcSEcCtD
Clobazam—Feeling abnormal—Cyclosporine—psoriasis	0.00024	0.000789	CcSEcCtD
Clobazam—Insomnia—Prednisolone—psoriasis	0.000239	0.000788	CcSEcCtD
Clobazam—Dizziness—Mycophenolic acid—psoriasis	0.000238	0.000783	CcSEcCtD
Clobazam—Mental disorder—Prednisone—psoriasis	0.000237	0.000781	CcSEcCtD
Clobazam—Malnutrition—Prednisone—psoriasis	0.000236	0.000776	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000235	0.000776	CcSEcCtD
Clobazam—Hyperhidrosis—Triamcinolone—psoriasis	0.000235	0.000775	CcSEcCtD
Clobazam—CYP2C18—FOXA1 transcription factor network—JUN—psoriasis	0.000234	0.00616	CbGpPWpGaD
Clobazam—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000234	0.00077	CcSEcCtD
Clobazam—Insomnia—Hydrocortisone—psoriasis	0.000234	0.00077	CcSEcCtD
Clobazam—Urticaria—Cyclosporine—psoriasis	0.000231	0.000761	CcSEcCtD
Clobazam—Myalgia—Betamethasone—psoriasis	0.00023	0.000759	CcSEcCtD
Clobazam—Myalgia—Dexamethasone—psoriasis	0.00023	0.000759	CcSEcCtD
Clobazam—Body temperature increased—Cyclosporine—psoriasis	0.00023	0.000757	CcSEcCtD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00023	0.00604	CbGpPWpGaD
Clobazam—Anxiety—Betamethasone—psoriasis	0.00023	0.000756	CcSEcCtD
Clobazam—Anxiety—Dexamethasone—psoriasis	0.00023	0.000756	CcSEcCtD
Clobazam—Vomiting—Mycophenolic acid—psoriasis	0.000229	0.000753	CcSEcCtD
Clobazam—Rash—Mycophenolic acid—psoriasis	0.000227	0.000747	CcSEcCtD
Clobazam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000227	0.00595	CbGpPWpGaD
Clobazam—Dermatitis—Mycophenolic acid—psoriasis	0.000226	0.000746	CcSEcCtD
Clobazam—Urticaria—Mycophenolate mofetil—psoriasis	0.000225	0.000742	CcSEcCtD
Clobazam—Headache—Mycophenolic acid—psoriasis	0.000225	0.000742	CcSEcCtD
Clobazam—Decreased appetite—Hydrocortisone—psoriasis	0.000225	0.00074	CcSEcCtD
Clobazam—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000224	0.000739	CcSEcCtD
Clobazam—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000223	0.000735	CcSEcCtD
Clobazam—Fatigue—Hydrocortisone—psoriasis	0.000223	0.000734	CcSEcCtD
Clobazam—Vision blurred—Prednisone—psoriasis	0.000222	0.000731	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000222	0.00073	CcSEcCtD
Clobazam—Insomnia—Triamcinolone—psoriasis	0.00022	0.000725	CcSEcCtD
Clobazam—Infection—Betamethasone—psoriasis	0.000219	0.000723	CcSEcCtD
Clobazam—Infection—Dexamethasone—psoriasis	0.000219	0.000723	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000218	0.00573	CbGpPWpGaD
Clobazam—Feeling abnormal—Prednisolone—psoriasis	0.000218	0.000718	CcSEcCtD
Clobazam—Visual impairment—Methotrexate—psoriasis	0.000218	0.000718	CcSEcCtD
Clobazam—Anaemia—Prednisone—psoriasis	0.000218	0.000717	CcSEcCtD
Clobazam—Nervous system disorder—Dexamethasone—psoriasis	0.000217	0.000713	CcSEcCtD
Clobazam—Nervous system disorder—Betamethasone—psoriasis	0.000217	0.000713	CcSEcCtD
Clobazam—Agitation—Prednisone—psoriasis	0.000217	0.000713	CcSEcCtD
Clobazam—Thrombocytopenia—Betamethasone—psoriasis	0.000216	0.000712	CcSEcCtD
Clobazam—Thrombocytopenia—Dexamethasone—psoriasis	0.000216	0.000712	CcSEcCtD
Clobazam—Erythema multiforme—Methotrexate—psoriasis	0.000214	0.000704	CcSEcCtD
Clobazam—Nausea—Mycophenolic acid—psoriasis	0.000213	0.000703	CcSEcCtD
Clobazam—Hyperhidrosis—Dexamethasone—psoriasis	0.000213	0.000703	CcSEcCtD
Clobazam—Hyperhidrosis—Betamethasone—psoriasis	0.000213	0.000703	CcSEcCtD
Clobazam—Feeling abnormal—Hydrocortisone—psoriasis	0.000213	0.000701	CcSEcCtD
Clobazam—Eye disorder—Methotrexate—psoriasis	0.000211	0.000696	CcSEcCtD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000211	0.00555	CbGpPWpGaD
Clobazam—Anorexia—Dexamethasone—psoriasis	0.00021	0.000693	CcSEcCtD
Clobazam—Anorexia—Betamethasone—psoriasis	0.00021	0.000693	CcSEcCtD
Clobazam—Urticaria—Prednisolone—psoriasis	0.00021	0.000692	CcSEcCtD
Clobazam—Fatigue—Triamcinolone—psoriasis	0.00021	0.000691	CcSEcCtD
Clobazam—Asthenia—Cyclosporine—psoriasis	0.000209	0.000687	CcSEcCtD
Clobazam—Hypotension—Dexamethasone—psoriasis	0.000206	0.00068	CcSEcCtD
Clobazam—Hypotension—Betamethasone—psoriasis	0.000206	0.00068	CcSEcCtD
Clobazam—Pruritus—Cyclosporine—psoriasis	0.000206	0.000678	CcSEcCtD
Clobazam—Urticaria—Hydrocortisone—psoriasis	0.000205	0.000676	CcSEcCtD
Clobazam—Body temperature increased—Hydrocortisone—psoriasis	0.000204	0.000673	CcSEcCtD
Clobazam—Asthenia—Mycophenolate mofetil—psoriasis	0.000204	0.00067	CcSEcCtD
Clobazam—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000203	0.00533	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000201	0.000663	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000201	0.000663	CcSEcCtD
Clobazam—Pruritus—Mycophenolate mofetil—psoriasis	0.000201	0.000661	CcSEcCtD
Clobazam—Myalgia—Prednisone—psoriasis	0.000201	0.000661	CcSEcCtD
Clobazam—Feeling abnormal—Triamcinolone—psoriasis	0.000201	0.000661	CcSEcCtD
Clobazam—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.0002	0.00526	CbGpPWpGaD
Clobazam—Anxiety—Prednisone—psoriasis	0.0002	0.000658	CcSEcCtD
Clobazam—Insomnia—Dexamethasone—psoriasis	0.0002	0.000658	CcSEcCtD
Clobazam—Insomnia—Betamethasone—psoriasis	0.0002	0.000658	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.0002	0.00525	CbGpPWpGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000199	0.000656	CcSEcCtD
Clobazam—Diarrhoea—Cyclosporine—psoriasis	0.000199	0.000655	CcSEcCtD
Clobazam—Mental disorder—Methotrexate—psoriasis	0.000198	0.000653	CcSEcCtD
Clobazam—Malnutrition—Methotrexate—psoriasis	0.000197	0.000649	CcSEcCtD
Clobazam—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000197	0.00517	CbGpPWpGaD
Clobazam—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000194	0.000639	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000194	0.00509	CbGpPWpGaD
Clobazam—Urticaria—Triamcinolone—psoriasis	0.000193	0.000637	CcSEcCtD
Clobazam—Body temperature increased—Triamcinolone—psoriasis	0.000192	0.000634	CcSEcCtD
Clobazam—Dizziness—Cyclosporine—psoriasis	0.000192	0.000633	CcSEcCtD
Clobazam—Decreased appetite—Dexamethasone—psoriasis	0.000192	0.000632	CcSEcCtD
Clobazam—Decreased appetite—Betamethasone—psoriasis	0.000192	0.000632	CcSEcCtD
Clobazam—Infection—Prednisone—psoriasis	0.000191	0.000629	CcSEcCtD
Clobazam—Gastrointestinal disorder—Betamethasone—psoriasis	0.000191	0.000628	CcSEcCtD
Clobazam—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000191	0.000628	CcSEcCtD
Clobazam—Fatigue—Dexamethasone—psoriasis	0.00019	0.000627	CcSEcCtD
Clobazam—Fatigue—Betamethasone—psoriasis	0.00019	0.000627	CcSEcCtD
Clobazam—Nervous system disorder—Prednisone—psoriasis	0.000189	0.000621	CcSEcCtD
Clobazam—Dizziness—Mycophenolate mofetil—psoriasis	0.000188	0.000618	CcSEcCtD
Clobazam—Skin disorder—Prednisone—psoriasis	0.000187	0.000615	CcSEcCtD
Clobazam—Hyperhidrosis—Prednisone—psoriasis	0.000186	0.000612	CcSEcCtD
Clobazam—Vision blurred—Methotrexate—psoriasis	0.000186	0.000611	CcSEcCtD
Clobazam—Asthenia—Hydrocortisone—psoriasis	0.000185	0.000611	CcSEcCtD
Clobazam—Vomiting—Cyclosporine—psoriasis	0.000185	0.000609	CcSEcCtD
Clobazam—Rash—Cyclosporine—psoriasis	0.000183	0.000604	CcSEcCtD
Clobazam—Anorexia—Prednisone—psoriasis	0.000183	0.000604	CcSEcCtD
Clobazam—Dermatitis—Cyclosporine—psoriasis	0.000183	0.000603	CcSEcCtD
Clobazam—Pruritus—Hydrocortisone—psoriasis	0.000183	0.000602	CcSEcCtD
Clobazam—Headache—Cyclosporine—psoriasis	0.000182	0.0006	CcSEcCtD
Clobazam—Anaemia—Methotrexate—psoriasis	0.000182	0.000599	CcSEcCtD
Clobazam—Feeling abnormal—Betamethasone—psoriasis	0.000182	0.000599	CcSEcCtD
Clobazam—Feeling abnormal—Dexamethasone—psoriasis	0.000182	0.000599	CcSEcCtD
Clobazam—Vomiting—Mycophenolate mofetil—psoriasis	0.00018	0.000594	CcSEcCtD
Clobazam—Rash—Mycophenolate mofetil—psoriasis	0.000179	0.000589	CcSEcCtD
Clobazam—Dermatitis—Mycophenolate mofetil—psoriasis	0.000179	0.000589	CcSEcCtD
Clobazam—Headache—Mycophenolate mofetil—psoriasis	0.000178	0.000585	CcSEcCtD
Clobazam—Diarrhoea—Hydrocortisone—psoriasis	0.000177	0.000582	CcSEcCtD
Clobazam—Leukopenia—Methotrexate—psoriasis	0.000176	0.000581	CcSEcCtD
Clobazam—Urticaria—Dexamethasone—psoriasis	0.000175	0.000578	CcSEcCtD
Clobazam—Urticaria—Betamethasone—psoriasis	0.000175	0.000578	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Prednisone—psoriasis	0.000175	0.000577	CcSEcCtD
Clobazam—Dizziness—Prednisolone—psoriasis	0.000175	0.000576	CcSEcCtD
Clobazam—Asthenia—Triamcinolone—psoriasis	0.000175	0.000575	CcSEcCtD
Clobazam—Body temperature increased—Dexamethasone—psoriasis	0.000175	0.000575	CcSEcCtD
Clobazam—Body temperature increased—Betamethasone—psoriasis	0.000175	0.000575	CcSEcCtD
Clobazam—Insomnia—Prednisone—psoriasis	0.000174	0.000573	CcSEcCtD
Clobazam—Nausea—Cyclosporine—psoriasis	0.000173	0.000569	CcSEcCtD
Clobazam—Pruritus—Triamcinolone—psoriasis	0.000172	0.000567	CcSEcCtD
Clobazam—Cough—Methotrexate—psoriasis	0.000172	0.000566	CcSEcCtD
Clobazam—Dizziness—Hydrocortisone—psoriasis	0.000171	0.000563	CcSEcCtD
Clobazam—Nausea—Mycophenolate mofetil—psoriasis	0.000168	0.000555	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000168	0.00442	CbGpPWpGaD
Clobazam—Myalgia—Methotrexate—psoriasis	0.000168	0.000552	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—IL13—psoriasis	0.000167	0.0044	CbGpPWpGaD
Clobazam—Decreased appetite—Prednisone—psoriasis	0.000167	0.000551	CcSEcCtD
Clobazam—Rash—Prednisolone—psoriasis	0.000167	0.00055	CcSEcCtD
Clobazam—Dermatitis—Prednisolone—psoriasis	0.000167	0.000549	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000166	0.000548	CcSEcCtD
Clobazam—Fatigue—Prednisone—psoriasis	0.000166	0.000546	CcSEcCtD
Clobazam—Headache—Prednisolone—psoriasis	0.000166	0.000546	CcSEcCtD
Clobazam—Constipation—Prednisone—psoriasis	0.000164	0.000542	CcSEcCtD
Clobazam—Vomiting—Hydrocortisone—psoriasis	0.000164	0.000541	CcSEcCtD
Clobazam—Rash—Hydrocortisone—psoriasis	0.000163	0.000537	CcSEcCtD
Clobazam—Dermatitis—Hydrocortisone—psoriasis	0.000163	0.000536	CcSEcCtD
Clobazam—Confusional state—Methotrexate—psoriasis	0.000162	0.000534	CcSEcCtD
Clobazam—Headache—Hydrocortisone—psoriasis	0.000162	0.000533	CcSEcCtD
Clobazam—Dizziness—Triamcinolone—psoriasis	0.000161	0.00053	CcSEcCtD
Clobazam—Infection—Methotrexate—psoriasis	0.00016	0.000526	CcSEcCtD
Clobazam—Feeling abnormal—Prednisone—psoriasis	0.000158	0.000522	CcSEcCtD
Clobazam—Asthenia—Betamethasone—psoriasis	0.000158	0.000522	CcSEcCtD
Clobazam—Asthenia—Dexamethasone—psoriasis	0.000158	0.000522	CcSEcCtD
Clobazam—Nervous system disorder—Methotrexate—psoriasis	0.000158	0.000519	CcSEcCtD
Clobazam—Thrombocytopenia—Methotrexate—psoriasis	0.000157	0.000518	CcSEcCtD
Clobazam—Nausea—Prednisolone—psoriasis	0.000157	0.000518	CcSEcCtD
Clobazam—Pruritus—Betamethasone—psoriasis	0.000156	0.000515	CcSEcCtD
Clobazam—Pruritus—Dexamethasone—psoriasis	0.000156	0.000515	CcSEcCtD
Clobazam—Skin disorder—Methotrexate—psoriasis	0.000156	0.000514	CcSEcCtD
Clobazam—Hyperhidrosis—Methotrexate—psoriasis	0.000155	0.000512	CcSEcCtD
Clobazam—Vomiting—Triamcinolone—psoriasis	0.000155	0.00051	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000154	0.00405	CbGpPWpGaD
Clobazam—Nausea—Hydrocortisone—psoriasis	0.000153	0.000506	CcSEcCtD
Clobazam—Rash—Triamcinolone—psoriasis	0.000153	0.000505	CcSEcCtD
Clobazam—Dermatitis—Triamcinolone—psoriasis	0.000153	0.000505	CcSEcCtD
Clobazam—Anorexia—Methotrexate—psoriasis	0.000153	0.000505	CcSEcCtD
Clobazam—Urticaria—Prednisone—psoriasis	0.000153	0.000503	CcSEcCtD
Clobazam—Headache—Triamcinolone—psoriasis	0.000152	0.000502	CcSEcCtD
Clobazam—Body temperature increased—Prednisone—psoriasis	0.000152	0.000501	CcSEcCtD
Clobazam—SLC6A11—Metabolism—CARM1—psoriasis	0.000151	0.00397	CbGpPWpGaD
Clobazam—Diarrhoea—Betamethasone—psoriasis	0.000151	0.000498	CcSEcCtD
Clobazam—Diarrhoea—Dexamethasone—psoriasis	0.000151	0.000498	CcSEcCtD
Clobazam—Hypotension—Methotrexate—psoriasis	0.00015	0.000495	CcSEcCtD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000147	0.00387	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000146	0.000482	CcSEcCtD
Clobazam—Dizziness—Dexamethasone—psoriasis	0.000146	0.000481	CcSEcCtD
Clobazam—Dizziness—Betamethasone—psoriasis	0.000146	0.000481	CcSEcCtD
Clobazam—Insomnia—Methotrexate—psoriasis	0.000145	0.000479	CcSEcCtD
Clobazam—Nausea—Triamcinolone—psoriasis	0.000145	0.000476	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000143	0.00376	CbGpPWpGaD
Clobazam—Somnolence—Methotrexate—psoriasis	0.000143	0.000471	CcSEcCtD
Clobazam—Vomiting—Dexamethasone—psoriasis	0.00014	0.000462	CcSEcCtD
Clobazam—Vomiting—Betamethasone—psoriasis	0.00014	0.000462	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.00014	0.00367	CbGpPWpGaD
Clobazam—Decreased appetite—Methotrexate—psoriasis	0.00014	0.00046	CcSEcCtD
Clobazam—Rash—Dexamethasone—psoriasis	0.000139	0.000459	CcSEcCtD
Clobazam—Rash—Betamethasone—psoriasis	0.000139	0.000459	CcSEcCtD
Clobazam—Dermatitis—Dexamethasone—psoriasis	0.000139	0.000458	CcSEcCtD
Clobazam—Dermatitis—Betamethasone—psoriasis	0.000139	0.000458	CcSEcCtD
Clobazam—Gastrointestinal disorder—Methotrexate—psoriasis	0.000139	0.000457	CcSEcCtD
Clobazam—Fatigue—Methotrexate—psoriasis	0.000139	0.000456	CcSEcCtD
Clobazam—Headache—Betamethasone—psoriasis	0.000138	0.000456	CcSEcCtD
Clobazam—Headache—Dexamethasone—psoriasis	0.000138	0.000456	CcSEcCtD
Clobazam—Asthenia—Prednisone—psoriasis	0.000138	0.000454	CcSEcCtD
Clobazam—Pruritus—Prednisone—psoriasis	0.000136	0.000448	CcSEcCtD
Clobazam—Feeling abnormal—Methotrexate—psoriasis	0.000132	0.000436	CcSEcCtD
Clobazam—Diarrhoea—Prednisone—psoriasis	0.000132	0.000433	CcSEcCtD
Clobazam—Nausea—Betamethasone—psoriasis	0.000131	0.000432	CcSEcCtD
Clobazam—Nausea—Dexamethasone—psoriasis	0.000131	0.000432	CcSEcCtD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00013	0.00342	CbGpPWpGaD
Clobazam—Urticaria—Methotrexate—psoriasis	0.000128	0.000421	CcSEcCtD
Clobazam—Dizziness—Prednisone—psoriasis	0.000127	0.000419	CcSEcCtD
Clobazam—Body temperature increased—Methotrexate—psoriasis	0.000127	0.000418	CcSEcCtD
Clobazam—Vomiting—Prednisone—psoriasis	0.000122	0.000403	CcSEcCtD
Clobazam—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000122	0.00321	CbGpPWpGaD
Clobazam—Rash—Prednisone—psoriasis	0.000121	0.000399	CcSEcCtD
Clobazam—Dermatitis—Prednisone—psoriasis	0.000121	0.000399	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	0.000121	0.00318	CbGpPWpGaD
Clobazam—Headache—Prednisone—psoriasis	0.00012	0.000397	CcSEcCtD
Clobazam—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.00012	0.00316	CbGpPWpGaD
Clobazam—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000117	0.00307	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000116	0.00304	CbGpPWpGaD
Clobazam—Asthenia—Methotrexate—psoriasis	0.000115	0.00038	CcSEcCtD
Clobazam—Nausea—Prednisone—psoriasis	0.000114	0.000376	CcSEcCtD
Clobazam—Pruritus—Methotrexate—psoriasis	0.000114	0.000374	CcSEcCtD
Clobazam—Diarrhoea—Methotrexate—psoriasis	0.00011	0.000362	CcSEcCtD
Clobazam—CYP2C18—Metabolism—NDUFA5—psoriasis	0.00011	0.00289	CbGpPWpGaD
Clobazam—Dizziness—Methotrexate—psoriasis	0.000106	0.00035	CcSEcCtD
Clobazam—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000105	0.00277	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL10—psoriasis	0.000105	0.00275	CbGpPWpGaD
Clobazam—Vomiting—Methotrexate—psoriasis	0.000102	0.000337	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—IL4—psoriasis	0.000102	0.00268	CbGpPWpGaD
Clobazam—Rash—Methotrexate—psoriasis	0.000101	0.000334	CcSEcCtD
Clobazam—Dermatitis—Methotrexate—psoriasis	0.000101	0.000333	CcSEcCtD
Clobazam—Headache—Methotrexate—psoriasis	0.000101	0.000332	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-B—psoriasis	9.96e-05	0.00262	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	9.94e-05	0.00261	CbGpPWpGaD
Clobazam—Nausea—Methotrexate—psoriasis	9.54e-05	0.000314	CcSEcCtD
Clobazam—CYP2C18—Metabolism—CYP2S1—psoriasis	9.34e-05	0.00245	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CAT—psoriasis	9.3e-05	0.00244	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	9.27e-05	0.00244	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	9.23e-05	0.00243	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-A—psoriasis	9.22e-05	0.00242	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.07e-05	0.00238	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	8.81e-05	0.00231	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	8.44e-05	0.00222	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	8.43e-05	0.00221	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	8.05e-05	0.00212	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	7.38e-05	0.00194	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—APOE—psoriasis	7.22e-05	0.0019	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	7.04e-05	0.00185	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.62e-05	0.00174	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPARG—psoriasis	6.29e-05	0.00165	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IFNG—psoriasis	6.15e-05	0.00162	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	6.15e-05	0.00162	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	6.14e-05	0.00161	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.92e-05	0.00156	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.72e-05	0.0015	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NDUFA5—psoriasis	5.4e-05	0.00142	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.38e-05	0.00141	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.37e-05	0.00141	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.71e-05	0.00124	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.65e-05	0.00122	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	4.61e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP2S1—psoriasis	4.59e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CARM1—psoriasis	4.56e-05	0.0012	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NDUFA5—psoriasis	4.08e-05	0.00107	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—psoriasis	3.98e-05	0.00105	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NDUFA5—psoriasis	3.98e-05	0.00105	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.96e-05	0.00104	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.8e-05	0.001	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	3.72e-05	0.000977	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.7e-05	0.000973	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.53e-05	0.000928	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP2S1—psoriasis	3.47e-05	0.000912	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP2S1—psoriasis	3.39e-05	0.00089	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CAT—psoriasis	2.8e-05	0.000737	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.63e-05	0.00069	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.53e-05	0.000664	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NDUFA5—psoriasis	2.45e-05	0.000645	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.29e-05	0.000603	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CARM1—psoriasis	2.24e-05	0.000589	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—APOE—psoriasis	2.18e-05	0.000573	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000548	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.97e-05	0.000517	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPARG—psoriasis	1.9e-05	0.000499	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.82e-05	0.000478	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.73e-05	0.000455	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CARM1—psoriasis	1.69e-05	0.000445	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CARM1—psoriasis	1.65e-05	0.000435	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-05	0.000416	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CAT—psoriasis	1.38e-05	0.000362	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—APOE—psoriasis	1.07e-05	0.000282	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CAT—psoriasis	1.04e-05	0.000274	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CARM1—psoriasis	1.02e-05	0.000268	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CAT—psoriasis	1.02e-05	0.000267	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPARG—psoriasis	9.33e-06	0.000245	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—APOE—psoriasis	8.1e-06	0.000213	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—APOE—psoriasis	7.9e-06	0.000208	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPARG—psoriasis	7.05e-06	0.000185	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPARG—psoriasis	6.88e-06	0.000181	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CAT—psoriasis	6.27e-06	0.000165	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—APOE—psoriasis	4.87e-06	0.000128	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPARG—psoriasis	4.24e-06	0.000111	CbGpPWpGaD
